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ABSTRACT 
DUBOIS, KAYLA The Theia Soteria: Alternative Design for Safer Initial Entry During 
Laparoscopic Procedures 
Department of Biomedical Engineering 
June 2019 
ADVISORS: Jennifer Currey, Takashi Buma, and Shane Cotter 
 
Laparoscopic procedures account for 15 million surgeries worldwide [1], with the 
initial entry into the peritoneal cavity accounting for 33-50% of all major laparoscopic 
complications [7]. This initial entry is the most dangerous as surgeons must enter the 
cavity using a sharp object with no visibility and space between the outer surface of the 
cavity and internal tissues. During the initial entry into the peritoneal cavity, the patients 
undergoing laparoscopic procedures are at a high risk for damage to internal organs and 
vasculature, necessitating the development of a device to protect these internal tissues 
and increase patient safety. 
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Background 
Laparoscopic procedures account for 15 million surgeries worldwide and are becoming 
the new standard for abdominal surgeries, such as cholecystectomies, appendectomies, 
tubo-ovarian procedures, hysterectomies, bariatric procedures, gastrointestinal 
procedures, urological cancer resections, and aortic aneurysms [1]. Laparoscopic 
procedures are preferred to their open procedure counterparts because they provide 
greater intraoperative visibility, are less expensive, and are less invasive, leading to 
patients experiencing less pain, a shorter recovery time, less scarring, reduced blood loss, 
and a shorter stay in the hospital [1][2]. The procedure is minimally invasive, requiring 4 
to 5 small incisions ranging from 0.5cm to 1cm in length to access the abdomen [3]. The 
small incisions, or ports, allow for the insertion of trocars which act as access points into 
the abdominal cavity for surgical instruments and the laparoscope, or camera, that are 
used throughout the procedure (Figure 1) [4]. 
 
Figure 1.  Diagram of laparoscopic procedure. The surgical tools are inserted 
through ports which act as access points for the remainder of the procedure [4]. 
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The initial entry during laparoscopic procedures is used to inflate the peritoneal cavity to 
increase visibility for the remainder of the procedure. There are multiple methods for 
achieving this initial entry, the two most common being entry using a Veress needle and 
the open technique. The Veress needle is inserted into the peritoneal cavity, releases 
carbon dioxide to inflate the cavity, then is removed and followed by the blind insertion 
of a sharp trocar. The open, or Hasson technique, involves a larger incision for the trocar 
to be inserted immediately without prior inflation of the cavity. Both techniques are 
dangerous as a sharp instrument is being inserted without visualization and without a 
preexisting pneumoperitoneum, or presence of gas within the peritoneal cavity [5]. Since 
the abdomen has not been inflated, the distance between the skin surface and aorta can be 
as low as 2 cm, leaving little room for error during the procedure [6]. Due to the lack of 
visibility and low room for error, the initial insertion accounts for 33-50% of all major 
laparoscopic complications [7]. These complications include, but are not limited to, 
vascular, bowel, uterine, and bladder damage.  
The Veress needle is the most commonly used technology for the initial entry into the 
peritoneal cavity, as it requires a smaller incision for entry. The current design of the 
Veress needle involves a cannula, which is an outer needle with a sharp distal point 
designed to penetrate the tissues, with a spring-loaded inner stylet with a dull tip intended 
to prevent damage when within body cavities (Figure 2). 
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The problem with the current Veress needles used in the operating room involves the lack 
of effective components protecting the internal tissues from damage. Since the surgeon 
cannot see into the cavity, they must rely on feel and their experience to determine if their 
position in the cavity is correct; if their position is not correct and they continue with the 
procedure, the patient is at risk for complications. There are currently two patents 
available with design elements intended to alert the surgeon of their position within the 
cavity, eliminating the risk for complications stemming from the lack of visibility.  
Figure 2. Current Veress needle design. (A) Outer cannula with 
sharp beveled tip to penetrate tissues. (B) Inner stylet with hole 
for release of carbon dioxide. (C) Spring in the handle to control 
the position of the stylet. 
A 
B 
C 
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In a patent for a Veress needle with an illuminated tip and cavity penetration indicator, 
the Veress needle is designed with an external light source on the surgeon’s end of the 
assembly to indicate whether the device is within the abdominal cavity. The light will 
turn off when the device has entered the cavity, as the switch is connected to the spring-
loaded stylet; when the stylet is under pressure and the spring is compressed, the light 
will be on. When the stylet is no longer under pressure, and the spring is relaxed, the light 
will turn off, signaling to the surgeon that the insufflation process can safely begin [8].  
The other useful patent for determining location within the cavity is a proximity detector 
paired with a medical instrument. The patent outlines the usage of the detector on the end 
of a medical instrument that determines the distance between the instrument and “an 
internal organ or member such as an artery” through the use of a transducer capable of 
sensing pressure changes [9]. While this technology was designed for use with general 
medical instruments, it can be adapted for use with a Veress needle to indicate the 
surgeon’s position within the peritoneal cavity.   
Neither of these patents are currently being used. The current Veress needle alerts the 
surgeon of their position within the cavity by either having a transparent handle, showing 
whether the spring is compressed, or by a red indicator that slides out of the top of the 
handle, indicating when the needle is under pressure. 
Problem Statement 
Laparoscopic procedures account for 15 million surgeries worldwide [1], with the initial 
entry into the peritoneal cavity accounting for 33-50% of all major laparoscopic 
complications [7]. This initial entry is the most dangerous as surgeons must enter the 
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cavity using a sharp object with no visibility and space between the outer surface of the 
cavity and internal tissues. During the initial entry into the peritoneal cavity, the 
patients undergoing laparoscopic procedures are at a high risk for damage to 
internal organs and vasculature, necessitating the development of a device to protect 
these internal tissues and increase patient safety. 
 
Design Objectives 
Objectives and sub-objectives were established for the device (Table 1). To determine 
which objectives were critical to the design of our device, we considered what the 
currently technology achieves successfully, as well as where it falls short.  Since the 
current technology results in operator mistakes that may lead to patient complications, the 
main objectives of our device were determined to be safe, user friendly, and marketable.  
Table 1. Objectives and sub-objectives established prior to designing the device. 
 
We decided that for a safe device to be created, the product must be biocompatible, allow 
for minimal organ damage, and maintain the minimally invasive nature of the current 
Objective Sub-Objective 
Safe 
Biocompatible 
No risk of organ damage 
Minimally Invasive 
User Friendly 
Handheld 
Easy to Operate 
Marketable 
Low Cost 
Time Efficient 
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laparoscopic procedure. The current techniques result in organ damage if not used 
properly, so the device needs to improve upon the safety of the procedure without 
becoming a more invasive procedure. 
To produce a device that is user friendly, we determined that the device needs to be easy 
to operate to prevent operator mistakes, as well as handheld. We need to create a device 
that does not change the procedure for the surgeons and can be operated using one hand. 
Finally, we believed our third objective, producing an instrument that would be 
marketable, could be achieved by creating a device that was low cost and time efficient. 
If our new device is not comparable in price and efficiency to the current products on the 
market, surgeons will be unlikely to switch to our device, even if it is safer.  
 
Device Functions and Specifications 
Based on current technologies and our design objectives, the main functions of our device 
can be split into two categories: achieves pneumoperitoneum and increases patient safety. 
To achieve pneumoperitoneum, we determined our device functions to be as follows: cuts 
through outer abdominal wall efficiently, enters through a small incision, and inflates the 
peritoneal cavity (Table 2).  To increase patient safety, we determined the functions of 
our device to be as follows: provides buffer to prevent organ damage, maintains the same 
procedure for the surgeons, and safely removes buffer (Table 2). For every function our 
device must fulfill, we determined a corresponding metric to determine the degree to 
which the device will complete the function requirement.  
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Table 2. Device functions and corresponding specification values. 
Category Function Metric Unit Margin
al Value 
Ideal 
Value 
Achieves  
Pneumoperitoneum 
Cuts through 
abdominal 
wall 
Force 
required 
for entry 
Newtons 
(N) 
68.67 
[10] 
68.67 
[10] 
Achieves 
Pneumoperitoneum 
Enters 
through 
small 
incision 
Size of 
incision 
Millimeters 
(mm) 
12 [11] 10 [11] 
Achieves 
Pneumoperitoneum 
Inflates the 
cavity 
Presence 
of port 
Binary yes 
or no 
  
Increases Safety Provides 
buffer to 
protect 
organs 
Presence 
of buffer 
component 
Binary yes 
or no 
  
Increases Safety Maintains 
procedure  
Alters 
procedure 
methods 
Binary yes 
or no 
  
Increases Safety Removes 
buffer 
Force 
required 
for buffer 
removal  
Newtons 
(N) 
1 N  
Less 
than 
removal 
force for 
current 
model  
3N  
Less than 
removal 
force for 
current 
model.  
 
Our design must complete a number of functions in order to compete with the current 
Veress needles and solve the problem we have identified. As the initial entry process is 
carried out, the device must first be able to penetrate the multiple layers of abdominal 
tissue under the average pressure that surgeons currently apply. The force generally 
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applied by a surgeon to penetrate the tissues is 68.67N [10]. We do not want to alter the 
force required because this method has become routine. Although our design ideally will 
give the surgeon the ability to apply a greater force while still not damaging the inner 
tissues, the transition to using our device should be simple and we want the process to 
feel the same for the surgeon.  
The device must also fit through a single small incision. Laparoscopic procedures begin 
by making a 12mm incision with a scalpel to put the Veress needle through [11]. Our 
device needs to be small enough to fit through that same incision; we must keep the 
cannula portion of the device small enough that this specification will not change.  
Next, we want a buffer to deploy to protect the inner tissues. This function is binary: 
either the buffer will deploy or it will not.  
Then, once safely positioned inside the cavity, the device must act like port to allow for 
the flow of carbon dioxide to inflate the peritoneal cavity. This function is also binary, as 
the device will either allow for the passage of carbon dioxide or it will not.  
Finally, our device must be able to remove the buffer in order to safely exit the body. The 
buffer must come off the device to ensure safe removal with a force less than or equal to 
the average force required for current model removal. The specification for these values 
were determined during validation testing.   
Design Requirements 
The most important requirements for our design were determined based on our objectives 
and functions, stemming from research and current models. The top requirements for our 
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device were as follows: must cut through tissues, must inflate the peritoneal cavity, 
requires a small incision for entry, and must have a buffer component (Table 3). The 
requirements were all determined with associated specification values that will serve as a 
baseline for our evaluations. 
Table 3. Design requirements and specifications. 
 Design Requirements Specification 
Penetrates through tissues 68.67 N [10] 
Provides port or cavity inflation Binary (port presence)  
Device size 12 mm midline incision [11] 
Buffer component Can withstand 68.67 N of entry force [10] 
Protects internal tissue Binary 
Buffer withdrawal force To be determined through testing - must 
be less than average force of the current 
model in order to ensure the buffer “pops” 
off 
 
The three critical components of our design that must be at least equivalent to the current 
design of a Veress needle are its ability to cut through tissues, inflate the peritoneal 
cavity, and do so through a small incision. The device must cut through tissues when a 
force of no greater than 68.67N is applied [10], inflate the cavity successfully which is 
indicated by the presence of carbon dioxide in the cavity, and the device must be inserted 
through an incision no larger than 12mm [11]. These design requirements are 
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successfully fulfilled by the current Veress needle models and are crucial to the 
procedure. 
To improve the current Veress needle, we added the requirements of a buffer component 
to protect the internal organs. This requirement stems from our objective of safety and 
addresses the main problem with the current Veress needle models of unwanted injury to 
inner structures. The buffer component must withstand the force of 68.67N and continue 
to protect the internal tissues when this force is applied [10]. In order for our design to 
function, the buffer must “pop” off the end of the device upon removal of the inner stylet. 
The buffer must come off of the stylet easily, with less force than is required for standard 
device removal. We will determine what force is required to remove a Veress needle 
from the body and compare this value to the force required for the buffer to come off the 
stylet to ensure it is less.  
These design requirements will be thoroughly evaluated individually to ensure the 
success of our device. 
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Proposed Design 
Pictured below is a 3D model and dimensional drawing of the final design of our 
prototype created with SolidWorks. The length of the cannula is 160mm and the diameter 
of the buffer is 6.35mm (Figure 3). 
Entry and Insufflation 
The buffer is attached at the end of the stylet and will begin inside of the cannula’s shaft, 
as the sharp beveled tip of the cannula pierces through tissues prior to the abdominal 
cavity. As this occurs, the end of the stylet will be under pressure by a spring located 
inside of the handle. Once the tip of the needle reaches the open space inside of the 
abdomen, the spring in the handle will force the stylet/buffer combination out of the 
cannula. The buffer will then expand, so that it is extended around the entirety of the 
sharp cannula’s outer surface, thus protecting the internal tissues of the patient from 
Figure 3. (Top) SolidWorks model of final design showing protective buffer (1), stylet with air port (2), sharp outer 
cannula (3), spring loaded handle (4), and pin for stylet/buffer retraction (5). (Bottom) Dimensional drawing of final 
design with buffer diameter and length of cannula noted in millimeters. 
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contact with the sharp tip of the needle. Once the tip of the needle is inside the patient’s 
abdominal cavity, air will be pumped from the handle-end of the stylet, travel through the 
hollow stylet, through an air port, and into the cavity of the patient, allowing for the 
successful insufflation necessary for the laparoscopic procedure. 
Retraction of Stylet Prior to Entry 
An issue with the rounded dome buffer component that we designed was that since the 
diameter of the buffer is larger than that of the cannula, once it is deployed out of the 
cannula, it will not be easily retracted back into the cannula. In order to account for this, a 
handle was designed and manufactured from PLA that contained a pin to keep the 
buffer/stylet component inside of the cannula prior to becoming in contact with the 
exterior tissues of the patient (Figure 4). 
Figure 4. Handle of prototype, containing a pin to keep the stylet and buffer 
component retracted (shown by red arrow) prior to the tip of the needle coming in 
contact with external tissues of patient. 
The pin seen above keeps the spring inside of the handle compressed, and thus the stylet 
connected to it inside of the shaft of the cannula. This pin serves as a way to prevent 
premature buffer deployment. Upon contact between the external tissues of the patient 
and the tip of the needle, the pin will keep the buffer/stylet component retracted. Once the 
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tip of the needle comes in contact with the patient’s external tissues, the pin will be 
removed, as the external tissues of the patient will be preventing deployment of the 
buffer. Upon entry into the abdominal cavity, the pressure that was exerted upon the tip 
of the needle, keeping the buffer component inside of the cannula, will no longer be 
present. This will allow for the buffer to be released into the cavity, encompassing the 
sharp cannula’s outer surface, and thus protecting the patient’s internal tissues. 
Removal of Needle 
Once the buffer has been deployed, and the abdominal cavity has been successfully 
insufflated, the needle will need to be removed. Due to the greater diameter of the buffer 
than the cannula, the needle cannot be taken out of the abdomen of the patient all at once. 
To account for this, the handle was made in two pieces that snap into one another and can 
be separated upon successful insufflation (Figure 5). 
 
Once the cavity has been inflated, the top of the handle of our device will be removed. 
This will allow for the stylet to be pulled through the cannula, and thus out of the body of 
the patient. In doing so, the buffer component will be forced off of the end of the stylet 
and will remain inside the patient’s body. To ensure the patient’s safety, the buffer 
Figure 5. Prototype showing handle opened up, allowing for removal of stylet component. Red arrow shows 
direction of pulling done by user to remove stylet component. 
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component will be fabricated from a biodegradable material that exhibits the necessary 
flexibility and durability of our buffer component. Once the buffer has been removed 
from the stylet and the stylet has been removed from the patient, the cannula can easily 
be taken out of the cavity, in a traditional needle fashion. 
Final Prototype 
Our final prototype combined all of these components (Figure 6). The prototype was 
fabricated out of stainless steel for the cannula, PLA for the handle, and Repro Rubber 
for the buffer. The buffer was created using a dome mold that the Repro Rubber was 
poured into, which resulted in the flexible but durable buffer prototype. We used the 
stylet and spring component from a current Veress needle.  
 
Validation of Design 
Based on our top design requirements of cutting through tissues, inflating the peritoneal 
cavity, requiring a small incision for entry, having a buffer component that protects the 
internal tissues, and having the buffer safely exit the body, we developed corresponding 
evaluation methods to ensure completion of these requirements (Table 4). 
Figure 6. Final prototype iteration. The buffer (1), stylet (2), cannula (3), spring (4), and handle (5) fit 
together to create a working prototype. The handle is shown in a cross sectional view.  
1 
2 3 
4 
5 
15 
 
Table 4. Evaluation methods for top five design requirements. 
Design 
Requirements 
Specification Evaluation 
Cuts through 
tissues 
3 attempts Use practice tissue to determine ease 
of access 
Inflates cavity Binary Open the valve and blow through the 
port to ensure the buffer does not 
prevent air flow 
Device size 12 mm midline 
incision [11] 
Cut a standard incision for 
laparoscopic surgery in practice 
tissue to ensure that the device fits 
inside 
Buffer 
component 
68.67 N or 15.44 lbs 
[10] 
Use practice tissue to ensure that the 
buffer prevents the cannula from 
puncturing tissues. Use scale to 
determine if the buffer can handle the 
standard force. 
Buffer safely 
exits the body 
TBD – the force 
required to remove 
needle from body 
Ensure that the buffer component 
does not break off when this force is 
applied. 
 
A practice tissue was used to test the device’s ability to cut through tissue and the 
device’s size. To test the device’s ability to cut through the tissue, we created the ‘Hot 
Glue Test’. For the hot glue test, we put hot glue on a piece of paper and then placed the 
practice tissue on top. We then pierced through the practice tissue with the cannula 
without applying excessive force for fifteen trials. After each trial, we removed the 
practice tissue and checked the hot glue for a clear puncture mark. If there was a mark in 
the glue, the trial was considered successful. We successfully pierced through the tissues 
on the first attempt for all trials; therefore, our device meets the requirement of piercing 
through the tissues within three attempts.  
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Since we did not change any of the insufflation mechanisms, validating that our device 
inflated the cavity was binary; we tested to see if it allowed for air flow or if the buffer 
prevented air flow. To test this, we opened the valve attached to the handle and blew 
through the handle where the carbon dioxide would be hooked up. With the buffer 
attached, our device allowed for air flow.  
To ensure that our device maintained the minimally invasive nature of the procedure, our 
device had to fit through a 12mm incision. To test this, we made a 12mm incision in 
practice tissue and inserted our device. Since the diameter of our cannula was 4mm, it fit 
through the 12mm incision with ease. 
To verify that our buffer successfully protected the tissues, we performed the ‘Hot Glue 
Test’ with the buffer encompassing the cannula. The buffer was successful in preventing 
puncturing for all fifteen trials. Following this test, we tested to ensure that the buffer 
could handle the standard force applied during laparoscopic initial entry, which is 
68.67N. To test this, we pushed our device with the buffer attached into a scale until the 
scale began to give inaccurate results. This value was 15.6lbs which can be converted to 
69.4N. Since this value is greater than the 68.67N applied during surgery, we concluded 
that our buffer would successfully prevent the cannula from puncturing tissues.  
Since our buffer is designed to pop off of the stylet upon removal from the body, we 
tested to ensure that it would not require excessive force during removal. The first step in 
this test was to remove the Veress needle from practice tissue using a force gauge to 
determine the average force required to remove the needle from the tissues. The needle 
was removed five times by each of us for a total of fifteen trials resulting in an average 
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removal force of 3.5N. To ensure that the buffer popped off of the stylet without 
exceeding this 3.5N force, we used the force gauge to pull the stylet up against the 
cannula until the buffer popped off. We had a total of fifteen trials resulting in an average 
force of 1.1N. Since the buffer popped off at a force less than 3.5N, we concluded that 
the buffer will be safely popped off of the stylet during removal without the need to apply 
extra force.  
Since we did not alter the main mechanisms of the device, the overall procedure was not 
altered significantly. However, we wanted to ensure that the weight of the device was not 
altered significantly, as that would affect the force required to successfully complete the 
procedure. We weighed the current Veress needle, which was found to be 0.02lbs. 
According to the literature, a Veress needle should weigh less than 4lbs [12]. Our 
completed prototype was found to weigh 0.03lbs, which is within the specification range, 
so we determined this would not affect the procedure significantly.  
Anticipated Regulatory Pathway 
If we were to take this project further and go through the process of attempting to get FDA 
approval, we would go the route of the 510(k) premarket notification similarly to the GRI-
Alleset Veress needle. The GRI-Alleset Veress needle 510(k) premarket notification was 
filed by GRI Medical and Electronic Technology Co., Ltd., 1805 Honggao Road, Xiuzhou 
Industry Zone, Jiaxing, China 214031 under the 510(k) number K172835. The device was 
filed with product code HIF (insufflator, laparoscopic) with a common name of Veress 
Needle and regulation name of Laparoscopic insufflator. The regulation number of the 
device was 21 CFR 884.1730 and it was classified as a class II device. The device was 
reviewed by the Obstetrics and Gynecology panel [13].  
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The GRI-Alleset Veress needle was found to be substantially equivalent to the Endopath 
Ultra Veress needle produced by Ethicon Endosurgery, Inc. Both devices are Class II 
laparoscopic insufflators intended to be used by surgeons in the operating room. The results 
of the performance testing determined that the GRI-Alleset Veress Needle is substantially 
equivalent to the Ethicon Endopath Ultra Veress Needle. Mechanical bench testing 
involving gas flow, leakage, max puncture force, rotational valve operation, stylet 
alignment, stylet strength, connector fitting, and audible rate were conducted and found to 
be equivalent to the predicate device.  
The GRI-Alleset Veress needle is similar to our device as it’s intended use is as a 
“disposable, single-use, sterile surgical instrument used during minimally invasive surgery 
for the establishment of peritoneum of the abdominal cavity prior to abdominal surgery.” 
Both devices include a stainless-steel needle with a spring-loaded inner stylet attached to a 
plastic handle with a red safety indicator. Where our devices differ is in our added buffer 
component that we intend to leave in the body following the procedure. This added element 
may add complications to our FDA approval route in comparison to similar devices.  
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Appendix A: Current Patents 
Figure A-2. Diagrammatic illustration of a surgeon's scalpel in a holder 
with a miniature acoustic transducer, with an expanded view of the 
electronic circuit [10] 
Figure A-1. Diagram of patent with an indicator light (32) switched on by 
the positioning of the spring (20) which triggers the switch (30) [9] 
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Appendix B: Objective and Sub-Objective Trees 
 
Figure B-1. Objective tree for sub-objectives relating to the main function of safe. 
Figure B-2. Objective tree for sub-objectives relating 
to the main function of marketable. 
 
Figure B-3. Objective tree for sub-objectives relating to the main 
function of user friendly. 
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Appendix C: Decision Matrices 
Figure C-1. Screening decision matrix. All of the potential designs were evaluated based on their satisfaction of the objectives. 
Any design that did not reduce the risk of organ damage were immediately eliminated. The top choice was the design 
incorporating ultrasonic proximity sensors.  
Figure C-2. Weighted decision matrix. The top designs determined by the screening matrix were weighted based on their 
satisfaction of the objectives. The top design was the design combining the elements from the umbrella and the ultrasonic 
proximity sensor.  
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Appendix D: Other Designs Not Developed Further 
 
 
Figure D-1. Peritoneal cavity entry device concept design, 
incorporating an ultrasonic proximity sensor. Design was 
determined to not be feasible for the scope of our project. 
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Figure D-2. Peritoneal cavity entry device concept design incorporating large guide, reducing the 
potential for human error. Design was determined to not be user friendly for the surgeon. 
 
 
Figure D-3. Peritoneal cavity entry device concept design that the final design we agreed upon was developed 
from. Incorporates a buffer between the sharp cannula and the internal tissues. 
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Figure D-4. Peritoneal cavity entry device concept design incorporating a 
suctioning technique. A device on the market was identified as already utilizing 
this technique, and therefore the device was determined to be an infringement 
upon IP. 
